Misoprostol, a Good Alternative for Preventing Postpartum Haemorrhage

Abstract

Postpartum haemorrhage is the leading cause of maternal mortality. There are ways to prevent it and reduce the risk of maternal mortality. Oxytocin is the drug of first choice recommended by the WHO but poses problems in its conservation and management. Increasingly, misoprostol is recommended in place of oxytocin given the similar and sometimes superior results; it offers in preventing PPH and the ease of storage, transport, and ease of use that it offers. It offers comparison to oxytocin. Several studies have shown the effectiveness of misoprostol and its acceptance by both patients and medical staff.